GTHR Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 Feb 2024 @ 13:14):

Stats
Today's Volume	4 000.00
Average Volume	0.00
Market Cap	35.00
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2011-12-31	Kolesnikov Avel	Sell	0	Common Stock
2012-01-04	Milici Antonio	Buy	6 400 000	Preferred B Stock
2011-12-31	Irizarry Tannya L	Buy	2 690 000	Preferred B Stock
2012-01-04	Milici Antonio	Buy	6 400 008	Preferred B Stock
2008-02-25	Mcnece Elmer Roy Jr	Buy	200 000	Common Stock

INSIDER POWER
0.00
Last 40 transactions
Buy: 17 783 008 \| Sell: 582 000

Volume Correlation

Long: -0.07 (neutral)

Short: 0.00 (neutral)

Signal:(36.168) Neutral

GeneThera, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

GeneThera, Inc. Correlation - Currency/Commodity

-0.81
( strong negative )

-0.86
( strong negative )

0.00
( neutral )

0.68
( moderate )

GeneThera, Inc. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Q3	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Q2	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Q1	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

GeneThera, Inc.

GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of zoonotic diseases. It offers treatments for zoonotic diseases, such as COVID -19 disease; paratuberculosis (Johne's disease) that is in Stage III clinical phase; mad cow and chronic wasting diseases; and E.coli and salmonella infections, as well as develops vaccine for mycobacterium avium sub paratuberculosis bacteria. The company's Molecular Robotic/AI Platform and Therapeutic strategy is designed to prevent the spread of disease from animals and allow to better control of zoonotic infectious agents. GeneThera, Inc. is based in Westminster, Colorado.